Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:ALUR NASDAQ:IRIX NASDAQ:NXGL NASDAQ:PTHL On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeALURAllurion Technologies$2.41-3.4%$2.71$2.15▼$22.25$18.57M-0.4574,613 shs66,894 shsIRIXIRIDEX$1.13+0.9%$1.11$0.78▼$2.14$19.03M0.62174,666 shs35,317 shsNXGLNexGel$2.43+9.0%$2.48$2.10▼$5.10$17.99M0.5764,803 shs44,620 shsPTHLPheton$0.63-5.2%$14.68$0.60▼$32.00$4.39MN/A3.64 million shs399,403 shsMetaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceALURAllurion Technologies-3.02%-10.26%-18.89%-24.13%-86.30%IRIXIRIDEX+0.89%-13.08%+5.61%+11.88%-40.21%NXGLNexGel+8.97%-9.67%+0.83%+0.83%-14.44%PTHLPheton-5.16%-25.56%-96.98%-88.01%+63,269,900.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationALURAllurion Technologies2.5567 of 5 stars3.45.00.00.00.01.70.6IRIXIRIDEX1.2734 of 5 stars0.05.00.00.02.71.70.0NXGLNexGel1.4151 of 5 stars0.05.00.00.02.32.50.0PTHLPhetonN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceALURAllurion Technologies 2.80Moderate Buy$22.83849.41% UpsideIRIXIRIDEX 0.00N/AN/AN/ANXGLNexGel 0.00N/AN/AN/APTHLPheton 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest PTHL, IRIX, NXGL, and ALUR Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/12/2025ALURAllurion TechnologiesZacks ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold(Data available from 8/16/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookALURAllurion Technologies$32.11M0.56N/AN/A($30.08) per share-0.08IRIXIRIDEX$48.67M0.39N/AN/AN/A∞NXGLNexGel$8.69M2.26N/AN/A$0.63 per share3.86PTHLPheton$450K9.25N/AN/A$0.94 per share0.67Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateALURAllurion Technologies-$26.15M-$12.50N/AN/AN/A-86.05%N/A-41.49%N/AIRIXIRIDEX-$8.91M-$0.33N/A∞N/A-10.95%-386.93%-17.42%N/ANXGLNexGel-$3.28M-$0.40N/A∞N/A-25.02%-49.37%-25.68%N/APTHLPheton-$660KN/A0.00∞N/AN/AN/AN/AN/ALatest PTHL, IRIX, NXGL, and ALUR EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/12/2025Q2 2025IRIXIRIDEX-$0.09-$0.06+$0.03-$0.06$13.10 million$13.57 million8/12/2025Q2 2025NXGLNexGel-$0.07-$0.09-$0.02-$0.09$3.08 million$2.88 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthALURAllurion TechnologiesN/AN/AN/AN/AN/AIRIXIRIDEXN/AN/AN/AN/AN/ANXGLNexGelN/AN/AN/AN/AN/APTHLPhetonN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioALURAllurion TechnologiesN/A2.091.88IRIXIRIDEX62.291.961.27NXGLNexGel0.161.741.15PTHLPhetonN/A12.3912.17Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipALURAllurion Technologies21.39%IRIXIRIDEX20.10%NXGLNexGel2.21%PTHLPhetonN/AInsider OwnershipCompanyInsider OwnershipALURAllurion Technologies22.40%IRIXIRIDEX7.40%NXGLNexGel20.55%PTHLPhetonN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableALURAllurion Technologies5017.46 million5.79 millionOptionableIRIXIRIDEX12016.99 million15.74 millionOptionableNXGLNexGel108.07 million6.41 millionNot OptionablePTHLPheton116.58 millionN/AN/APTHL, IRIX, NXGL, and ALUR HeadlinesRecent News About These CompaniesPheton Holdings Addresses Market Volatility and RumorsAugust 6, 2025 | theglobeandmail.comPheton Holdings Ltd Addresses Market Volatility and Denies Acquisition RumorsAugust 1, 2025 | quiverquant.comQPheton Holdings Ltd Issues Statements Addressing Recent Market Activity and Misleading Rumors | ...August 1, 2025 | gurufocus.comPheton Holdings Ltd Issues Statements Addressing Recent Market Activity and Misleading RumorsAugust 1, 2025 | globenewswire.comPheton Holdings Ltd. Cl A (PTHL) Stock Price Today - WSJJuly 31, 2025 | wsj.comChinese Health Care Stock Pheton Holdings Collapses After Short Seller Warns Of Manipulation By 'Overseas Scammers'July 30, 2025 | benzinga.comPTHL: Trading Resumes for Pheton Holdings LtdJuly 29, 2025 | gurufocus.comPheton (NASDAQ:PTHL) Trading Up 2.3% - Time to Buy?July 19, 2025 | marketbeat.comPheton Holdings Ltd (PTHL) - Yahoo FinanceJune 28, 2025 | finance.yahoo.comPTHL Pheton Holdings Ltd - Seeking AlphaJune 27, 2025 | seekingalpha.comPheton Holdings Ltd Announces Closing of Initial Public OfferingSeptember 6, 2024 | globenewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimePTHL, IRIX, NXGL, and ALUR Company DescriptionsAllurion Technologies NYSE:ALUR$2.40 -0.09 (-3.41%) Closing price 08/15/2025 03:54 PM EasternExtended Trading$2.42 +0.01 (+0.42%) As of 08/15/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon), as well as offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. Allurion Technologies Inc. is headquartered in Natick, Massachusetts.IRIDEX NASDAQ:IRIX$1.13 +0.01 (+0.89%) As of 08/15/2025 04:00 PM EasternIRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. It offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform MicroPulse transscleral laser therapy; G-Probe, which is used in procedures to treat uncontrolled glaucoma; G-Probe and G-Probe Illuminate, which are used in procedures to treat refractory glaucoma; and EndoProbe family of products for use in vitrectomy procedures. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, veterinary practices, and office clinics. It markets its products through direct and independent sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View, California.NexGel NASDAQ:NXGL$2.43 +0.20 (+8.97%) Closing price 08/15/2025 04:00 PM EasternExtended Trading$2.42 -0.02 (-0.62%) As of 08/15/2025 07:07 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. The company was incorporated in 2009 and is based in Langhorne, Pennsylvania.Pheton NASDAQ:PTHL$0.63 -0.03 (-5.16%) Closing price 08/15/2025 04:00 PM EasternExtended Trading$0.67 +0.04 (+5.90%) As of 08/15/2025 07:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Pheton Holdings Ltd. operates as a holding company with interests in providing healthcare solutions. The firm through its subsidiaries engages in the development and commercialization of brachytherapy TPS specifically used for radioactive particle implantation, a type of radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company was founded in 1998 and is headquartered in Beijing, China. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Applied Materials' Knee-Jerk Sell-Off Is Your Signal to Buy Buffett’s Mystery Buy Revealed, and It’s a Big Bet on UNH Deere’s Sell-Off Could Be a Long-Term Buying Chance 3 Restaurant Stocks That Will Outperform in Q3 and Q4 Cisco Systems: The Only AI Stock Income Investors Need to Own Gartner’s RSI Just Sank to 11: That’s a Setup You Can’t Ignore Arista Networks: Cashing In as the Tollbooth for AI Traffic Green Dot's 30% Rally: Turnaround Takes Off on Explosive Earnings Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access